Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats I: Magnetic resonance imaging
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Objective: The mammalian target of rapamycin (m TOR) pathway has received increasing attention as a potential antiepileptogenic target. Treatment with the m TOR inhibitor rapamycin after status epilepticus reduces the development of epilepsy in a rat model. To study whether rapamycin mediates this effect via restoration of blood–brain barrier (BBB) dysfunction, contrast‐enhanced magnetic resonance imaging (CE‐MRI) was used to determine BBB permeability throughout epileptogenesis. Methods: Imaging was repeatedly performed until 6 weeks after kainic acid–induced status epilepticus in rapamycin (6 mg/kg for 6 weeks starting 4 h after SE) and vehicle‐treated rats, using gadobutrol as contrast agent. Seizures were detected using video monitoring in the week following the last imaging session. Results: Gadobutrol leakage was widespread and extensive in both rapamycin and vehicle‐treated epileptic rats during the acute phase, with the piriform cortex and amygdala as the most affected regions. Gadobutrol leakage was higher in rapamycin‐treated rats 4 and 8 days after status epilepticus compared to vehicle‐treated rats. However, during the chronic epileptic phase, gadobutrol leakage was lower in rapamycin‐treated epileptic rats along with a decreased seizure frequency. This was confirmed by local fluorescein staining in the brains of the same rats. Total brain volume was reduced by this rapamycin treatment regimen. Significance: The initial slow recovery of BBB function in rapamycin‐treated epileptic rats indicates that rapamycin does not reduce seizure activity by a gradual recovery of BBB integrity. The reduced BBB leakage during the chronic phase, however, could contribute to the decreased seizure frequency in post–status epilepticus rats treated with rapamycin. Furthermore, the data show that CE‐MRI (using step‐down infusion with gadobutrol) can be used as biomarker for monitoring the effect of drug therapy in rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy
van Vliet, E. A., da Costa Araujo, S., Redeker, S., van Schaik, R., Aronica, E., & Gorter, J. A. (2007) · Brain · doi:10.1093/brain/awl318 · Cited by 775
Self-citationTGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., & Friedman, A. (2007) · Brain · doi:10.1093/brain/awl317 · Cited by 567
Houde, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P.-G., Bellmann, K., Deshaies, Y., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1324 · Cited by 456 · cited 1×
“Effects on growth have also been reported in mice,(20) and are not unexpected, considering the known role of RAP on cell size and growth via S6K1 and 4EBP1/eIF4E,(26) lipid metabolism, and the reduction of adipose tissue.(27) The extent of brain growth reduction, which can even cause parts of the brain to shrink, appe…”
BackgroundAngiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Rigau, V., Morin, M., Rousset, M.-C., de Bock, F., Lebrun, A., Coubes, P., Picot, M.-C., Baldy-Moulinier, M., Bockaert, J., Crespel, A., et al. (2007) · Brain · doi:10.1093/brain/awm118 · Cited by 429
Cited by
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
“Rapamycin also rescued BBB impairment caused by cytokines in an in vitro assay 51 . mTOR inhibitors may increase the expression of tight junction proteins by activating the ERK1/2 signalling pathway 191 .”
InfluentialSelf-citationThe pericyte–glia interface at the blood–brain barrier
Giannoni, P., Badaut, J., Dargazanli, C., De Maudave, A. F., Klement, W., Costalat, V., & Marchi, N. (2018) · Clinical Science · doi:10.1042/cs20171634 · Cited by 81
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
Self-citation
Metadata
- Authors
- van Vliet, E. A., Otte, W. M., Wadman, W. J., Aronica, E., Kooij, G., de Vries, H. E., Dijkhuizen, R. M., & Gorter, J. A.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2015-12-22
- Volume
- 57
- Issue
- 1
- Pages
- 59-69
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2202300859
- Cited by
- 65
- References
- 6
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.